INTS
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
03/06/2026
Back to search
Official data from USPTO
IMODI
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
33
Latest update
03/07/2026
Trademark type
Word
Nice classes
42
Filing date
04/11/2017
Registration date
05/22/2018
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/06/2024
Last transaction
03/07/2026
Responsible office
United States Patent and Trademark Office
Status code
709
Official register
Principal Register
Drawing code
4
Owner type
98
Owner location
FR
Examiner
FOSDICK, GEOFFREY A
Law office
M20
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
O. S. (pessoa física)
ONCODESIGN
Representatives
John Zaccaria Notaro, Michalos & Zaccaria P.C.
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Scientific and medical research in the field of cancerology; computer modeling services in the field of cancerology; development of experimental models of cancer; biomedical research; biological analyses and pharmacological analyses; consultancy pertaining to pharmacology; medical and scientific research in the field of cancer treatment and diagnosismolecular and pharmacological evaluation of the efficacy and toxicity of cancer treatments; scientific researchidentification of diagnosticprognostic and predictive biomarkers in the field of cancerology; product development in relation to production of innovative biological models in vitroex vivoin vivo and biological products for biomedical research in the field of cancerology; biomedical research services; analysis of translational biomedical data; design and development of computer software and databases for biomedical data processing and management
Publications
History of USPTO decisions and trademark events.
33 publications found
INPC
INVALIDATION PROCESSED
03/06/2026
INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
08/06/2025
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
12/12/2024
C71T
CANCELLED SECTION 71
12/06/2024
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
08/16/2024
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
09/21/2018
FICS
FINAL DISPOSITION NOTICE SENT TO IB
08/30/2018
FIMP
FINAL DISPOSITION PROCESSED
08/30/2018
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
08/22/2018
R.PR
REGISTERED-PRINCIPAL REGISTER
05/22/2018
GPNX
NOTIFICATION PROCESSED BY IB
03/09/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/06/2018
PUBO
PUBLISHED FOR OPPOSITION
03/06/2018
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
02/21/2018
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
02/21/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/14/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/31/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/31/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/31/2018
ALIE
ASSIGNED TO LIE
01/30/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/18/2018
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12/26/2017
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12/26/2017
RFNT
REFUSAL PROCESSED BY IB
08/04/2017
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
07/20/2017
RFRR
REFUSAL PROCESSED BY MPU
07/20/2017
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
07/13/2017
CNRT
NON-FINAL ACTION WRITTEN
07/12/2017
MAFR
APPLICATION FILING RECEIPT MAILED
07/11/2017
DOCK
ASSIGNED TO EXAMINER
07/07/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/07/2017
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
07/06/2017
Continuous trademark protection
Get notified about every new filing that threatens IMODI or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.